癌症干细胞和位:免疫疗法耐药性的挑战
Yonglong Pan1,2,3, Chaoyi Yuan1,2, Chenglong Zeng1,2
1Hepatic Surgery Center, Clinical Medical Research Center of Hepatic Surgery at Hubei Province, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Molecular cancer
|February 25, 2025
概括
癌症干细胞 (CSCs) 驱动瘤生长和抵抗免疫治疗等疗法. 针对CSC及其保护性利基对于有效的癌症治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 癌症干细胞 (CSCs) 是瘤进展,转移,免疫逃避和治疗抵抗的关键驱动因素.
- CSCs表现出可塑性,在茎状和差异化状态之间动态切换,有助于治疗弹性.
- 的CSC微环境提供免疫特权,并促进免疫抑制,进一步保护CSC.
研究的目的:
- 审查CSC及其在免疫疗法抵抗中的利基的关键作用.
- 突出CSC及其利基市场对治疗失败的贡献机制.
- 强调综合战略的必要性,以克服CSC介导的抵抗.
主要方法:
- 文献综述侧重于癌症干细胞,它们的可塑性,利基互动和免疫治疗耐药性.
- 分析研究CSC特性及其对治疗结果的影响的研究.
- 综合当前关于CSCs在免疫逃避和抑制的背景下的理解.
主要成果:
- 细胞核细胞对瘤的进展,转移,免疫逃避和对治疗的耐药性至关重要,包括免疫检查点抑制剂和采用细胞疗法 (ACT).
- CSC的可塑性允许适应治疗压力,增强生存和复发.
- 该CSC位积极支持CSC茎,并创建一个免疫抑制环境,阻碍抗瘤免疫力.
结论:
- CSC及其利基市场是癌症免疫治疗成功的重要障碍.
- 了解CSC可塑性和利基互动对于开发新型治疗策略至关重要.
- 需要针对CSC及其微环境的综合性方法来克服免疫疗法耐药性并改善患者的治疗结果.
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
01:26Stem Cell Niche
5.0K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.0K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K